Statistically significant distinctions between patients with and without ILD
| ILD patients (n=34) | No-ILD patients (n=61) | P | |
|---|---|---|---|
| Current mean age (years) | 61.8±14.5 | 58.6±13.2 | 0.330 |
| Mean disease duration (years) | 11.6±9.8 | 9.2±9.3 | 0.250 |
| Anti-centromere antibody (%) | 5 (15) | 48 (79) | <0.001 |
| Anti-Scl70 antibody (%) | 18 (55) | 4 (7) | <0.001 |
| Diffuse cutaneous disease (%) | 14 (41) | 5 (8) | <0.001 |
| Digital ulcers (%) | 19 (54) | 11 (18) | <0.001 |
| NYHA Functional Classification (%) | 23 (67) | 30 (49) | 0.017 |
| Tricuspid regurgitation (%) | 26 (84) | 24 (45) | 0.001 |
| DLCOsb <60 (%) | 7 (64) | 0 (0) | 0.056 |
| Hypoxemia at rest (%) | 8 (27) | 4 (7) | 0.013 |
| Gastrointestinal involvement (%) | 10 (48) | 9 (24) | 0.060 |
| Death (%) | 5 (16) | 1 (2) | 0.020 |